Related Experiment Videos
The Assessing Patients' Preferred Treatments (APPT-1) study
1HIV Research Department, Chelsea and Westminster Hospital, London, UK. gm@moyle.demon.co.uk
International Journal of STD & AIDS
|November 18, 2003
Summary
People with HIV prefer once-daily antiretroviral therapy. However, factors like side effects and convenience influence their final regimen choice, indicating a complex decision-making process.
Area of Science:
- Infectious Diseases
- HIV/AIDS Research
- Patient-Centered Care
Background:
- Limited data exists on patient preferences for antiretroviral therapy (ART) administration.
- Understanding patient preferences is crucial for optimizing HIV treatment adherence and outcomes.
- Key factors like administration frequency, pill burden, and side effect profiles significantly impact treatment choices.
Purpose of the Study:
- To investigate patient preferences for antiretroviral regimens among people with HIV.
- To assess the importance of administration frequency, tablet load, and the balance between side effects and convenience.
- To identify factors influencing the selection of HIV treatment regimens.
Main Methods:
- A standardized questionnaire was administered to 504 people with HIV.
- The study was conducted across five major European countries.
- Data collected focused on patient preferences for ART administration and regimen characteristics.
Main Results:
- A strong preference for once-daily administration of antiretroviral therapy was observed.
- Patient preferences were influenced by multiple factors beyond just frequency.
- The trade-off between treatment convenience and potential side effects emerged as a significant consideration.
Conclusions:
- Once-daily dosing is a highly desired characteristic for antiretroviral regimens.
- Individual patient factors and the balance of convenience versus side effects play a critical role in regimen selection.
- Future HIV treatment strategies should prioritize patient preferences to enhance adherence and therapeutic success.